Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2025-12-25 @ 2:44 AM
NCT ID:
NCT05030233
Eligibility Criteria:
Inclusion Criteria:
* Born prematurely between 27 and 30 weeks post-menstrual age.
* Born to mothers who are English-speaking and able to provide informed consent.
* No more than 10 days old at the time of enrollment.
Exclusion Criteria:
* Diagnosed with Grade III/IV intraventricular hemorrhage or other neurologic abnormality (e.g. seizure disorder) affecting sensory perception or motor function.
* Diagnosed with a congenital anomaly requiring surgery during the neonatal period.
* Receiving scheduled steroids or vasopressors.
* Skin conditions that preclude the attachment of sensors.
* Diagnosed with Neonatal Abstinence Syndrome or born to mothers with known illicit drug use, except marijuana, during pregnancy.
* Diagnosed with chromosomal abnormalities.
* Requiring special isolation with universal gloving for potentially infectious pathogens.
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
10 Days
Study:
NCT05030233
Study Brief:
Protocol Section:
NCT05030233